Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Nomination Committee Appointed for Spago Nanomedical's Annual General Meeting 2026
Healthcare & PharmaceuticalCompany Update

Nomination Committee Appointed for Spago Nanomedical's Annual General Meeting 2026

December 8, 2025 5:00 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - In accordance with the instructions to the nomination committee resolved by the Annual General Meeting ("AGM"), a nomination committee for the 2026 AGM has been appointed. The nomination committee for the 2026 AGM has been formed based on the largest owners as of September 30, 2025, who wish to participate in the nomination committee. The nomination committee has the following composition, which...

Read more
Monthly Newsletter - November: Momentum, Deliveries, and Continued Expansion
Healthcare & PharmaceuticalCompany Update

Monthly Newsletter - November: Momentum, Deliveries, and Continued Expansion

December 8, 2025 4:15 AM

iZafe Group (STO:IZAFE-B) - November marked yet another month of strong progress. New municipal rollouts, additional signed agreements, and continued growing interest all confirm that we are firmly establishing ourselves as one of the most attractive options for safe and digital medication management both in Sweden and across our expanding European markets, where interest is rising notably in the Netherlands. We continue to grow in usage, in...

Read more
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
Healthcare & PharmaceuticalPartnerships

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

December 8, 2025 1:20 AM

Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced the closing of its previously reported sale of the Just - Evotec Biologics Toulouse site plus an indefinite technology license to Evotec's continuous manufacturing platform technology to Sandoz AG (SIX:SDZ / OTCQX:SDZNY), effective 05 December 2025. In total, potential payments may exceed US$ 650 m plus royalties on a...

Read more
Umbrella Labs Introduces Research-Use-Only MK-677 Ibutamoren Program To Support High-Rigor Endocrine And Metabolic Bench Science
Healthcare & PharmaceuticalCompany Update

Umbrella Labs Introduces Research-Use-Only MK-677 Ibutamoren Program To Support High-Rigor Endocrine And Metabolic Bench Science

December 8, 2025 1:10 AM

Umbrella Labs today announced the launch of its research-use-only MK-677 (Ibutamoren, Nutrobal) program, built around a liquid formulation and an accompanying methods framework designed for laboratories that require traceable, assay-ready materials for endocrine and metabolic research. Under this initiative, Umbrella Labs is formalizing a complete workflow for MK-677 that spans sourcing, analytical verification, stability mapping, and...

Read more
MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers
Healthcare & PharmaceuticalCompany Update

MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers

December 7, 2025 8:55 PM

MSP Recovery, Inc. (NASDAQ:MSPR) (the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announces that the staff of the U.S. Securities and Exchange Commission ("SEC") has informed the Company that it has concluded its investigation relating to MSP Recovery, Inc., and does not intend to recommend enforcement action to the Commission against the Company, its CEO, John H. Ruiz, or its...

Read more
Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science
Healthcare & PharmaceuticalCompany Update

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

December 7, 2025 7:00 AM

The Drug Enforcement Administration is facing the most profound institutional crisis in its 52-year history. Recent federal indictments, Supreme Court rulings, Department of Justice admissions, and extensive investigative reporting reveal an agency that has not merely failed its mission-it has actively inverted it. The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have access to controlled...

Read more
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering

December 7, 2025 3:00 AM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has engaged a U.S. investment bank to serve as its capital markets advisor in connection with the Company's intention to pursue a potential cross-listing of its common shares on the Nasdaq Stock Market LLC ("Nasdaq" or the "Exchange") and to evaluate and structure a potential concurrent equity financing. The...

Read more
AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio
Healthcare & PharmaceuticalMergers and Acquisitions

AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio

December 6, 2025 12:45 PM

Ameerex Corporation (OTC:HIRU) ("Ameerex" or the "Company"), a natural-resources group owned and managed by high-profile Qatari investors, announces that it has signed a Memorandum of Understanding (MOU) to acquire a 100% interest in the Corcoran Canyon Silver-Gold Project in Nye County, Nevada. The NI 43-101 Technical Report for Corcoran Canyon outlines a substantial Inferred Mineral Resource totaling approximately 45.6 million...

Read more
Shinoda Dental Named Official Distributor of VHF Milling Machines, Strengthening Its Position in Digital Dentistry
Healthcare & PharmaceuticalCompany Update

Shinoda Dental Named Official Distributor of VHF Milling Machines, Strengthening Its Position in Digital Dentistry

December 6, 2025 6:30 AM

Shinoda Dental is a top global supplier of dental and lab equipment. They are proud to announce that they are now an authorized distributor of VHF milling machines. This expands their advanced CAD/CAM products for dental labs and clinics around the world. People recognize VHF dental milling machines for their precision, efficiency, and flexibility. Professionals around the world trust them for both wet and dry milling. This new partnership...

Read more
Exquisite Brows & Spa Introduces Premier Lash Lift and Tint Services Across Melbourne and Sydney
Healthcare & PharmaceuticalCompany Update

Exquisite Brows & Spa Introduces Premier Lash Lift and Tint Services Across Melbourne and Sydney

December 6, 2025 6:20 AM

Exquisite Brows & Spa, a leading beauty destination in Australia, is proud to announce the expansion of its services with professional lash lift and tint treatments, alongside expert waxing solutions. As interest grows in searches for waxing near me and lash enhancement services, the spa continues to deliver exceptional, client-focused care designed to enhance natural beauty and confidence. Elevating Natural Beauty with Lash Lift and Tint The...

Read more
Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc.
Healthcare & PharmaceuticalCompany Update

Queue Ventures Announces Closing of Brokered Private Placement of Subscription Receipts of Custom Fundco Inc.

December 5, 2025 7:15 PM

Queue Ventures Ltd. ("Queue") is pleased to announce that, further to its news releases dated December 9, 2024 and May 30, 2025, Custom FundCo Inc. ("FundCo") has completed the first closing (the "First Closing") in respect of its brokered private placement (the "Offering") of subscription receipts of FundCo ("Subscription Receipts"). Pursuant to the First Closing, FundCo issued an aggregate of 1,200,000 Subscription Receipts at a price of...

Read more
LeanBiome Reviews (URGENT REPORT) Shocking Findings on Belly Fat, Probiotic Stability & Real User Results
Healthcare & PharmaceuticalAdvertorial

LeanBiome Reviews (URGENT REPORT) Shocking Findings on Belly Fat, Probiotic Stability & Real User Results

December 5, 2025 4:25 PM

LeanBiome has exploded across women's weight-loss discussions in 2025, driven by claims that a multi-strain probiotic blend, especially Lactobacillus gasseri, rhamnosus, fermentum, and the GreenSelect Phytosome complex, may target stubborn belly fat through gut-microbiome modulation rather than stimulants. With orders surging, complaints emerging about copycats, and growing curiosity about whether LeanBiome truly influences cravings, digestion,...

Read more
G-Plans GLP-1 Weight Loss: Personalized Telehealth Treatment With Clinician-Led Metabolic Assessment
Healthcare & PharmaceuticalAdvertorial

G-Plans GLP-1 Weight Loss: Personalized Telehealth Treatment With Clinician-Led Metabolic Assessment

December 5, 2025 4:05 PM

This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented in this article. All opinions and descriptions are based on publicly available details and are intended to help readers make informed decisions. Medical Note: GLP-1 medications are prescription treatments that...

Read more
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Healthcare & PharmaceuticalCompany Update

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

December 5, 2025 3:20 PM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced that it has entered into a warrant inducement agreement for the immediate exercise of the total outstanding Series A Warrants and Series B Warrants that the Company issued on July 14, 2025 (the "Warrants")....

Read more
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
Healthcare & PharmaceuticalCompany Name Change

Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement

December 5, 2025 11:00 AM

Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced the highly anticipated market launch of its flagship nutraceutical, Maxasome™. Derived exclusively from 100% pure Exosome-Like Nanoparticles (ELNs) extracted from the high-value Yellow Oyster Mushroom (Pleurotus citrinopileatus), Maxasome™ is an unprecedented, all-natural, multi-modal cytoprotective agent...

Read more
Medical Care Technologies Inc. (OTC Pink:MDCE) Closes Reg A - Dilution Ends, Growth Phase Begins
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC Pink:MDCE) Closes Reg A - Dilution Ends, Growth Phase Begins

December 5, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that its Regulation A Tier 1 Offering will formally conclude on December 6, 2025, marking a major milestone in the Company's corporate transition and strengthening its capital structure. With the completion of the offering, no additional shares will be issued through the Reg A, concluding the dilution period that supported early-stage development and strategic subsidiary...

Read more
NEI Features Upstream Therapeutics Co-Founder Kristine Jordan in Keynote on DNA-Informed Wellness and Mental Health
Healthcare & PharmaceuticalEnvironmental, Social and Governance

NEI Features Upstream Therapeutics Co-Founder Kristine Jordan in Keynote on DNA-Informed Wellness and Mental Health

December 5, 2025 7:00 AM

The Neurodivergent Empowerment Institute (NEI) is pleased to announce that Kristine M. Jordan, LISW-S, CMHIMP, co-founder and CEO of Upstream Therapeutics, will be a featured presenter at NEI's "Celebrate & Connect" Grand Opening Wellness Event on Sunday, December 14, 2025, at 2200 2nd Ave S, Suite 134, St. Petersburg, FL. Jordan will present a signature talk on how genetics, nutrigenomics, and precision lifestyle medicine can be used to better...

Read more
Cantargia Provides Update on Overall Survival Data from TRIFOUR
Healthcare & PharmaceuticalRegulatory

Cantargia Provides Update on Overall Survival Data from TRIFOUR

December 5, 2025 1:50 AM

Cantargia (STO:CANTA) - Cantargia AB (Publ) (NASDAQ:CANTA.ST) today announced an update on overall survival results from the Phase 1b/2 TRIFOUR study evaluating nadunolimab in triple-negative breast cancer (TNBC). The analysis showed no difference in median overall survival (mOS) between the group treated with nadunolimab plus gemcitabine/carboplatin (GC) and the GC control group. Notably, both groups achieved a survival duration of 26 months,...

Read more
Prostadine Reviews (URGENT REPORT) Shocking Findings on Urinary Flow, Hard-Water Toxins & Buyer Complaints
Healthcare & PharmaceuticalAdvertorial

Prostadine Reviews (URGENT REPORT) Shocking Findings on Urinary Flow, Hard-Water Toxins & Buyer Complaints

December 4, 2025 6:10 PM

Concerns around prostate enlargement, hormonal shifts, and disrupted urinary flow have surged in 2025, and with them, the demand for transparent, medically grounded reviews. ProstaDine, a plant-based liquid supplement built around detoxification and marine botanicals, has become one of the most-searched formulas among men over 40. But rising interest has also triggered skepticism, counterfeit listings, and a wave of mixed consumer feedback. This...

Read more
iGenics Reviews (URGENT REPORT) The Truth About Ingredients, Complaints, Eye Strain Results & Whether It Really Works
Healthcare & PharmaceuticalAdvertorial

iGenics Reviews (URGENT REPORT) The Truth About Ingredients, Complaints, Eye Strain Results & Whether It Really Works

December 4, 2025 3:50 PM

The surge of interest in iGenics reviews across the wellness space is not accidental. As digital eye strain, blue light exposure, and age-related changes accelerate in every demographic, consumers are actively searching for credible, non-pharmaceutical ways to support long-term vision health. This urgent report examines how the iGenics vision supplement positions itself within that growing demand, and whether its ingredients, User Feedback, And...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?